Information on the Outcome of the Procurement Procedure under Request for Proposal RFP - RG0162_03 – ACTIVE PHARMACEUTICAL INGREDIENTS
In connection with the implementation of the project entitled “Development and Clinical Confirmation of the Efficacy, Safety and Bioavailability of an Innovative Triple-Combination Medicinal Product for the Treatment of Lipid Disorders” (hereinafter: the “Project”), planned to be co-financed from the state budget by the Medical Research Agency under the call for proposals entitled “Development of Innovative Solutions in the Area of New Pharmaceutical Forms of Authorised Medicinal Products, Generic Medicinal Products and Biosimilar Medicinal Products” (ABM/2026/1), and acting pursuant to § 8 of the template grant agreement, Adamed Pharma S.A. hereby informs that the contract will be awarded to the following bidder:
Midas Pharma Polska Sp. z o.o.